Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
OMHE US​

Omni Health, Inc.(OMHE US)

$0.00+0.000.00%(Market Closed · 20:00:00 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Omni Health, Inc. — Company Profile

Omni Health, Inc., through its subsidiary, Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida. It provides health, wellness, and pharmacy services; and manufactures, sells, and distributes anti-aging cream. The company is headquartered in Hialeah, Florida. Omni Health, Inc. is a subsidiary of LX Retail Group, Inc.

Sector
Consumer Staples
Industry
Tobacco
Exchange
UU
CEO
Andrey Soloviev
Headquarters
Hialeah, FL, US
IPO Date
Jan 6, 2015
Website
www.omnihealth.md

Key Metrics

Price
$0.00
Market Cap
$48.82K
Revenue (TTM)
$4.70M
Net Income (TTM)
$1.27M
EPS (TTM)
0.00
P/E (TTM)
0.10
P/B (TTM)
0.01
Dividend Yield
0.00%
ROE (TTM)
35.26%
ROA (TTM)
22.88%
Operating Margin
8.64%
Beta
-12.59

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Omni Health, Inc., through its subsidiary, Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida. It provides health, wellness, and pharmacy services; and manufactures, sells, and distributes anti-aging cream. The company is headquartered in Hialeah, Florida. Omni Health, Inc. is a subsidiary of LX Retail Group, Inc.

Website
www.omnihealth.md
Location
Hialeah, FL, US
Phone305-558-8551
Employees0
CEOAndrey Soloviev
Sector
Consumer Staples
Industry
Tobacco
IPO DateJan 6, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(49)

Expand
  • 15-15DNotice of suspension of duty to file (Section 15(d))27 Oct 2017
  • NT 10-KFY 2017ended 30 Apr 201731 Jul 2017
  • 8-KDirector/Officer Changes & Compensatory Arrangements21 Jul 2017
  • 8-KEntry into Material Agreement3 Apr 2017
  • 10-QQ3ended 31 Jan 201724 Mar 2017
  • CORRESPFiling review correspondence20 Mar 2017
  • NT 10-QQ3ended 31 Jan 201715 Mar 2017
  • 10-QQ2ended 31 Oct 20161 Feb 2017
  • 10-QQ1ended 31 Jul 201623 Jan 2017
  • 8-KDirector/Officer Changes & Compensatory Arrangements18 Jan 2017
  • 10-KFY 2016ended 30 Apr 201625 Nov 2016
  • 8-KCharter/Bylaw Amendment; Fiscal Year Change26 Oct 2016
  • 8-KDirector/Officer Changes & Compensatory Arrangements6 Oct 2016
  • NT 10-QQ2ended 31 Jul 201614 Sep 2016
  • NT 10-KFY 2016ended 30 Apr 201629 Jul 2016
  • 8-KCompleted Acquisition or Disposition of Assets27 Jun 2016
  • 8-KDirector/Officer Changes & Compensatory Arrangements8 Jun 2016
  • 8-KDirector/Officer Changes & Compensatory Arrangements19 Apr 2016
  • 8-KDirector/Officer Changes & Compensatory Arrangements24 Mar 2016
  • 10-QQ3ended 31 Jan 201622 Mar 2016

Key Stats

Trading

Px/Chg 1D$0.00 / +0.00%
Avg Volume6.06K
Beta-12.59
Mkt Cap48.82K
FD Mkt Cap29.29K

Float

Shrs Out/Float976.38M / 737.00M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$902.84K

Current Valuation

EV1.51M
EV/EBITDA-2.33
EV/Sales0.29
P/B0.01
P/S0.01
FCF Yield-728.30%
ROE35.26%
ROA22.88%
Current Ratio1.25

Estimates

P/E0.10
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgOct '26
PRICE-BASED RATIOS
Price / Earnings0.040.04
Price / Sales0.010.01
Price / Book Value0.010.01
Price / Free Cash Flow-0.14-0.14
ENTERPRISE VALUE METRICS
Enterprise Value1.51.5
Enterprise Value / Sales0.320.32
Enterprise Value / EBITDA1.171.17
Enterprise Value / EBIT1.191.19

Enterprise Value Bridge

Metric22 Oct '26
Price (As of 22 Oct '26)0.00
Basic Shares976.38
Market Cap0.0
−In-the-Money Convertible Debt—
+Operating Leases—
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Pension Liabilities—
Enterprise Value0.0

Related companies

Altria Group, Inc.

MO US

RLX Technology Inc.

RLX US

White Fox Ventures, Inc.

AWAW US

BOTS, Inc./PR

BTZI US

22nd Century Group, Inc.

XXII US

ML Capital Group, Inc.

MLCG US

Philip Morris International Inc.

PM US

British American Tobacco p.l.c.

BTAFF US